DOCSLIB.ORG

MTA2 Silencing Attenuates the Metastatic Potential of Cervical

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MTA2 Silencing Attenuates the Metastatic Potential of Cervical Lin et al. Cell Death and Disease (2021) 12:451 https://doi.org/10.1038/s41419-021-03729-1 Cell Death & Disease ARTICLE Open Access MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis Chia-Liang Lin1,Tsung-HoYing2,3, Shun-Fa Yang 1,4, Hui-Ling Chiou5, Yong-Syuan Chen1,Shao-HsuanKao 1,4 and Yi-Hsien Hsieh1,4 Abstract Metastasis-associated protein 2 (MTA2) is a transcription factor that is highly associated with matrix metalloproteinase 12 (MMP12). Thus, we hypothesized that MTA2 may regulate MMP12 expression and is involved in cervical cancer metastasis. Results showed that MTA2 and MMP12 were highly expressed in cervical cancer cells, and MTA2 knockdown reduced MMP12 expression and inhibited the metastasis of cervical cancer cells in xenograft mice. MMP12 knockdown did not influence the viability of cervical cancer cells but clearly inhibited cell migration and invasion both in vitro and in vivo. MMP12 was highly expressed in cervical tumor tissues and correlated with the poor survival rate of patients with cervical cancer. Further investigations revealed that p38 mitogen-activated protein kinase (p38), mitogen-activated protein kinase kinase 3 (MEK3), and apoptosis signal-regulating kinase 1 (ASK1) were involved in MMP12 downregulation in response to MTA2 knockdown. Results also demonstrated that p38-mediated Y-box 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; binding protein1 (YB1) phosphorylation disrupted the binding of AP1 (c-Fos/c-Jun) to the MMP12 promoter, thereby inhibiting MMP12 expression and the metastatic potential of cervical cancer cells. Collectively, targeting both MTA2 and MMP12 may be a promising strategy for the treatment of cervical cancer. Introduction molecular mechanism of cervical carcinogenesis must be Cervical cancer is one of the most life-threatening comprehensively explored to develop more specific and malignancy in women in the developing countries1,2. effective treatments to this disease. Various types of treatments combining surgeries, radio- Distal metastasis is often found in tumor recurrence, therapy, and chemotherapy have been developed to heal and it is the major cause of death for most patients with precancerous lesions and eradicate aggressive and malig- cancer. Compared with the mechanisms for tumor nant cervical carcinomas3. However, many patients with initiation and regulation of tumor growth, the molecular cervical cancer still suffer from recurrence and distal process of metastasis remains unclear. Many dynamic metastasis of cancer after treatments. Therefore, the cellular processes are involved in the dissemination of cancer cells from the primary site to distant sites, including changes in cytoskeletal structure, cell–cell and Correspondence: Shao-Hsuan Kao ([email protected]) or Yi- cell–extracellular matrix (ECM) interaction, and ECM Hsien Hsieh ([email protected]) 4 1Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan degradation . Matrix metalloproteinases (MMPs) belong 2Department of Obstetrics and Gynecology, School of Medicine, College of to the zinc protease family and play a pivotal role in tumor Medicine, Chung Shan Medical University, Taichung, Taiwan metastasis mainly by inducing ECM degradation and sti- Full list of author information is available at the end of the article 5 These authors contributed equally: Chia-Liang Lin, Tsung-Ho Ying mulating tumor growth . Edited by S. Tait © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a linktotheCreativeCommons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Official journal of the Cell Death Differentiation Association Lin et al. Cell Death and Disease (2021) 12:451 Page 2 of 12 Metastasis-associated protein 2 (MTA2) is a transcrip- reaction (RT-PCR) was conducted using GoScript Reverse tional regulator belonging to the metastasis tumor- Transcriptase (Madison, WI, USA). Quantitative RT-PCR associated family. Previous studies demonstrated that (qRT-PCR) was performed using the StepOne Real-Time MTA2 plays an important role in cytoskeletal organization PCR System (Applied Biosystems, Foster City, CA, USA). and transcription, as well as in the promotion of the The primers used for qRT-PCR were: MTA2, (F) 5ʹ-TGT metastatic potential of tumor cells6,7. However, the role of ACC GGG TGG GAG ATT AC-3ʹ,(R)5ʹ- TGA GGC TAC MTA2 in the metastatic ability of cervical cancer cells TAG AAA TGT CCC TG-3ʹ;MMP12,(F)5ʹ-CATGAA remains poorly understood. Here, we showed that MTA2 is CCG TGA GGA TGT TGA -3ʹ,(R)5ʹ-GCA TGG GCT highly expressed in cervical tumor tissues and is associated AGG ATT CCA CC-3ʹ; and glyceraldehyde 3-phosphate with the poor prognosis of cervical cancer. To explore the dehydrogenase (GAPDH), (F) 5ʹ-CAT CAT CCC TGC CTC role of MTA2 in the metastatic potential of cervical cancer TAC TG-3ʹ,(R)5ʹ-GCC TGC TTC ACC ACC TTC-3ʹ cells, we established MTA2-knockdown cervical cancer (Mission Biotech, Taipei, Taiwan). Relative quantitation of cells to investigate the effects of MTA2 knockdown on cell gene expression was normalized with endogenous GAPDH ΔΔ motility, invasiveness, and in vivo metastasis. via the 2- Ct method. Materials and methods Cell culture and gene knockdown by shRNA lentivirus Reagents and antibodies infection Chemicals and antibodies without specific indication Human cervical cancer cell lines HeLa, SiHa, and C33A were purchased from Sigma-Aldrich (St. Louis, MO, USA). were cultured in Dulbecco’s modified Eagle’s medium The antibodies source and dilution factor: MTA2 (sc- (DMEM) containing 10% v/v fetal bovine serum (FBS, 55566; 1:1000), ERK (sc-514302; 1:1000), p-p38 mitogen HyClone, Thermo Fisher, Waltham, MA, USA), 50 U/mL activated protein kinase (p-p38) (sc-166182; 1:1000), p38 penicillin, and 50 μg/mL streptomycin (Sigma-Aldrich) in (sc-7972; 1:1000), p-JNK (sc-6254; 1:1000), JNK (sc-571; a humidified incubator supplied with 5% CO2. MTA2 and 1:1000), ASK1 (sc-5294; 1:1000), p-MEK3 (sc-8407; MMP12 knockdown was achieved by the transfection of 1:1000), MEK3 (sc-960; 1:1000), c-Jun (sc-74543; 1:1000), specific shRNA lentiviral constructs (shMTA2 and c-Fos (sc-8047; 1:1000), lamin B (sc-374015; 1:2000), YB1 shMMP12, National RNA Interference Core Facility, (sc-18057; 1:1000), β-actin (sc-69879; 1:2000), and Institute of Molecular Biology, Academia Sinica, Taipei, peroxidase-conjugated antibodies against mouse IgG or Taiwan). The target sequences of shMTA2 and shMMP12 rabbit IgG (1:10000) were obtained from Santa Cruz Bio- were 5ʹ-AGGGAGTGAGGAGTGAATTAA-3ʹ and 5ʹ- technology (Santa Cruz, CA, USA). MMP12 (ab66157; CTTGCTTGACTCTACTATTAA-3ʹ, respectively. Luci- 1:1000) were purchased from Abcam (Cambridge, UK). ferase lentiviral construct (shLuc) was used as control. The Phospho(p)-ASK1 (#3764; 1:1000), phospho(p)-ERK1/2 transfection assay was conducted according to the guide- (#9101; 1:1000) and phospho(p)-YB1 (#2900; 1:1000) were lines of the Institutional Biosafety Committee of Chung purchase from Cell Signaling Technology (Beverly, MA, Shan University. HEK293T cells were used for target USA). Human cervix cancer array (CR805) were pur- lentivirus production. Both HeLa and SiHa cells with chased from US Biomax, Inc (Rockville, MD, USA). stable MTA2- and MMP12-knockdown were generated by lentiviral infection and then followed by puromycin Immunohistochemical staining selection for 2 weeks. Inhibition efficiency of the shRNA Tissues were fixed, blocked, sliced, and incubated with constructs was confirmed via Western blot and qRT-PCR. primary antibodies against human MTA2 or anti- MMP12. After washing with PBS, the reacted sections Western blot analysis were incubated with peroxidase-conjugated second anti- Cells were washed with PBS, collected, and then lysed bodies and then reacted with diaminobenzidine solution with RIPA buffer (Cell Signaling, Beverly, MA, USA) for for signal visualization as previously described8. Protein protein extraction. The extracted proteins were separated expression in the immunohistochemical staining was by a 10% SDS–polyacrylamide gel and then transferred quantified according to the immunoreactivity score. onto a PVDF membrane (Immobilon P, Merck Millipore, Billerica, MA, USA). The membrane was blocked with 2% Reverse transcription and real-time quantitative skimmed milk and then incubated with primary anti- polymerase chain reaction bodies, peroxidase-conjugated secondary antibody (Santa Cells were harvested, and total RNA was extracted using Cruz Technology), and with a chemiluminescence sub- Isol-RNA-Lysis Reagent (Gaithersburg, MD, USA). Com- strate (GE Healthcare, London, UK) as previously plementary DNA was acquired via reverse-transcription of described9. Chemiluminescent signals were acquired and total RNA by using
Load more

Recommended publications
  • Single Nucleotide Variants in Metastasis-Related Genes Are
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE HHS Public Access provided by CDC Stacks Author manuscript Author ManuscriptAuthor Manuscript Author Mol Carcinog Manuscript Author . Author manuscript; Manuscript Author available in PMC 2018 March 01. Published in final edited form as: Mol Carcinog. 2017 March ; 56(3): 1000–1009. doi:10.1002/mc.22565. Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry Michelle R. Roberts1,2,3, Lara E. Sucheston-Campbell4, Gary R. Zirpoli5, Michael Higgins6, Jo L. Freudenheim3, Elisa V. Bandera7, Christine B. Ambrosone2, and Song Yao2 1Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 2Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 3Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, NY 4Division of Pharmacy Practice and Science, The Ohio State University, Columbus, OH 5Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 6Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, NY 7Rutgers Cancer Institute of New Jersey, New Brunswick, NJ Abstract Background—Single nucleotide polymorphisms (SNPs) in pathways influencing lymph node (LN) metastasis and estrogen receptor (ER) status in breast cancer may partially explain inter- patient variability in prognosis. We examined 154 SNPs in 12 metastasis-related genes for associations with breast cancer risk, stratified by LN and ER status, in European-American (EA) and African-American (AA) women. Methods—2,671 women enrolled in the Women’s Circle of Health Study were genotyped.
    [Show full text]
  • A Gene Regulatory Network Armature for T Lymphocyte Specification
    Supporting Information Georgescu et al. 10.1073/pnas.0806501105 SI Text orientation in the multidimensional space, while the relative magnitude of gene expression variation is still visible on the 2D Computational Methods pls projection. All of the 2D visualizations included use the Partial Least Squares (PLS) Analysis of Normal Developmental Gene above transformations. Expression Change. PLS regression analysis was performed to find The lengths of the DN-stage vectors in the pls principal axis a hyper plane of reduced dimensionality relating the expression space indicate the extent to which these axes are explanatory of variation of the studied genes to the developmental stages DN1, the corresponding DN state. Because in the full multidimen- DN2, DN3A, DN3B, and DN4. PLS begins by characterizing the sional space this length is the same for all five DN stages, the five developmental stages DN1–DN4 as orthogonal axes in length of these vectors in the 2D projection shows the relative five-dimensional space. Each of the assayed genes is represented extent to which the DN stages are represented in the projection. as a point in this space, such that the gene’s coordinate along Long vectors indicate DN stages well represented in the projec- each axis corresponds to its expression level at the corresponding tion. In the multidimensional space, the cosine of the angle developmental stage. Genes with similar expression changes between the vectors corresponding to two variables (genes during development will tend to form clusters in this space, and/or DN stages) gives the correlation between the two vari- whereas genes with distinctly different expression profiles will ables.
    [Show full text]
  • Metastasis-Associated Protein 2 Represses NF-Ƙb to Reduce Lung Tumor Growth And
    Author Manuscript Published OnlineFirst on August 14, 2020; DOI: 10.1158/0008-5472.CAN-20-1158 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Metastasis-associated protein 2 represses NF-ƙB to reduce lung tumor growth and 2 inflammation 3 Nefertiti El-Nikhely1#, Annika Karger1, Poonam Sarode1, Indrabahadur Singh1§, Andreas 4 Weigert2, Astrid Wietelmann1, Thorsten Stiewe3, Reinhard Dammann4, Ludger Fink5, 5 Friedrich Grimminger6, Guillermo Barreto1,7, Werner Seeger1,6,8, Soni S. Pullamsetti1,6, Ulf R. 6 Rapp1, Rajkumar Savai1,6,8* 7 Affiliations: 1Max Planck Institute for Heart and Lung Research, Member of the German 8 Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Bad 9 Nauheim, Germany; 2Institute of Biochemistry I, Goethe University Frankfurt, Frankfurt, 10 Germany; 3Institute of Molecular Oncology, Member of the DZL, Philipps-University 11 Marburg, Marburg, Germany; 4Institute for Genetics; member of the German Center for 12 Lung Research (DZL), Justus-Liebig-University, Giessen, Germany; 5Institute of Pathology and 13 Cytology, UEGP, Wetzlar, Germany; 6Department of Internal Medicine, Member of the DZL, 14 Member of CPI, Justus Liebig University, Giessen, Germany; 7Brain and Lung Epigenetics 15 (BLUE), Glycobiology, Cell Growth and Tissue Repair Research Unit (Gly-CRRET), Université 16 Paris-Est Créteil (UPEC), Créteil, France; 8Institute for Lung Health (ILH), Justus Liebig 17 University, Giessen, Germany; #present address: Department of Biotechnology, Institute of 18 Graduate Studies and Research, Alexandria University, Egypt; §present address: Emmy 19 Noether Research Group Epigenetic Machineries and Cancer, Division of Chronic 20 Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • 1 Unique Protein Interaction Networks Define the Chromatin Remodeling
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.27.428018; this version posted January 28, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Unique Protein Interaction Networks Define The Chromatin Remodeling Module of The NuRD Complex Mehdi Sharifi Tabar1,2, Caroline Giardina1, Yue Julie Feng1, Habib Francis1, Hakimeh Moghaddas Sani3, Jason K. K. Low3, Joel P. Mackay3, Charles G. Bailey1,2,4, John E.J. Rasko1,2,5,6 1Gene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW, 2050, Australia 2Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, 2006, Australia 3School of Life & Environmental Sciences, The University of Sydney, Sydney, NSW, 2006, Australia 4Cancer and Gene Regulation Laboratory Centenary Institute, The University of Sydney, Camperdown, NSW, 2050, Australia 5Cell and Molecular Therapies, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia 6Corresponding author 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.27.428018; this version posted January 28, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The combination of four proteins and their paralogues including MBD2/3, GATAD2A/B, CDK2AP1, and CHD3/4/5, which we refer to as the MGCC module, form the chromatin remodeling module of the Nucleosome Remodeling and Deacetylase (NuRD) complex, a gene repressor complex. Specific paralogues of the MGCC subunits such as MBD2 and CHD4 are amongst the key repressors of adult-stage fetal globin and provide important targets for molecular therapies in beta (β)-thalassemia.
    [Show full text]
  • Snail/PRMT5/Nurd Complex Contributes to DNA Hypermethylation in Cervical Cancer by TET1 Inhibition
    Cell Death & Differentiation (2021) 28:2818–2836 https://doi.org/10.1038/s41418-021-00786-z ARTICLE Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition 1,2 2 1 3 4 4 1 Jie Gao ● Ruiqiong Liu ● Dandan Feng ● Wei Huang ● Miaomiao Huo ● Jingyao Zhang ● Shuai Leng ● 1 3 3 3 3 4 1,4 Yang Yang ● Tianshu Yang ● Xin Yin ● Xu Teng ● Hefen Yu ● Baowen Yuan ● Yan Wang Received: 15 September 2020 / Revised: 8 April 2021 / Accepted: 15 April 2021 / Published online: 5 May 2021 © The Author(s) 2021. This article is published with open access Abstract The biological function of PRMT5 remains poorly understood in cervical cancer metastasis. Here, we report that PRMT5 physically associates with the transcription factor Snail and the NuRD(MTA1) complex to form a transcriptional-repressive complex that catalyzes the symmetrical histone dimethylation and deacetylation. This study shows that the Snail/PRMT5/ NuRD(MTA1) complex targets genes, such as TET1 and E-cadherin, which are critical for epithelial-mesenchymal transition (EMT). This complex also affects the conversion of 5mC to 5hmC. This study demonstrates that the Snail/ PRMT5/NuRD(MTA1) complex promotes the invasion and metastasis of cervical cancer in vitro and in vivo. This study 1234567890();,: 1234567890();,: also shows that PRMT5 expression is upregulated in cervical cancer and various human cancers, and the PRMT5 inhibitor EPZ015666 suppresses EMT and the invasion potential of cervical cancer cells by disinhibiting the expression of TET1 and increasing 5hmC, suggesting that PRMT5 is a potential target for cancer therapy. Introduction These authors contributed equally: Jie Gao, Ruiqiong Liu, Protein arginine methyltransferase 5 (PRMT5) is a type II Dandan Feng protein arginine methyltransferase (PRMT) that has been Edited by R Johnstone reported to catalyze the symmetrical dimethylation of argi- nine [1].
    [Show full text]
  • Supporting Information
    Supporting Information Ji et al. 10.1073/pnas.1613195113 SI Materials and Methods We acquired the Haploinsufficiency Scores (32) and the Ge- Identification of EGs. We identified 3,023 protein-coding EGs nome-Wide Haploinsufficiency Scores (33) for genome-wide annotated with 50 Mouse Phenotype (MP) terms, including prediction of the probability of haploinsufficiency. For each prenatal, perinatal, and postnatal lethal phenotypes from the prediction model, the raw scores were ranked and converted to MGI (23) (Table S8). The MGI database was also used to extract percentiles. The histograms and estimated density curves were 4,995 protein-coding NEGs with nonlethal phenotypes in the plotted using ggplot2 (geom_histogram and geom_line) in R. mouse. Phenotype data from the IMPC database portal (24) Burden Analysis of Mutations in EGs in ASD Families. expanded the lethal gene list with the addition of 252 lethal The Simons genes and 101 genes with subviable phenotypes. We further Simplex Collection contains genetic and phenotypic information supplemented the nonlethal gene list with 701 genes with viable from 2,600 ASD families, each of which has one child affected phenotypes from the IMPC. In the case of discrepancy in the with ASD and unaffected parents and siblings (34). ASD pro- bands were defined by clinical consensus from the Autism Di- reported lethality status between the MGI and the IMPC, we – deferred to the phenotypes reported by the IMPC, because these agnostic Interview Revised (57) and the Autism Diagnostic mouse lines were generated on a defined C57BL/6N background Observation Schedule (58). Multiple individual phenotypic measures, including the SRS (35) and IQ, were available (8, 26).
    [Show full text]
  • MTA2 Triggered R-Loop Trans-Regulates BDH1-Mediated Β-Hydroxybutyrylation and Potentiates Propagation of Hepatocellular Carcinoma Stem Cells
    Signal Transduction and Targeted Therapy www.nature.com/sigtrans LETTER OPEN MTA2 triggered R-loop trans-regulates BDH1-mediated β-hydroxybutyrylation and potentiates propagation of hepatocellular carcinoma stem cells Signal Transduction and Targeted Therapy (2021) 6:135; https://doi.org/10.1038/s41392-021-00464-z Dear editor, NuRD complex was different in the CD133+ and CD133− HCC MTA2 is associated with invasively malignant phenotypes in cells, and its function was inhibited in the former. Hence, the many types of cancers,1 but the molecular mechanism remains MTA2-HDAC2-CHD4 complex is closely related to HCC stemness. unclear. Studies on the role of MTA2 mostly concentrated on it as (Supplementary Fig. S2) We performed chromatin immunopre- a component of the NuRD complex, which functions via the NuRD cipitation (ChIP) assay on MTA2 in the two groups of cells to complex to inhibit the transcription of downstream target genes.2 determine how the complex functions and what target genes Whether MTA2 could directly exert transcriptional regulation are regulated. In the CD133+ group, we found a large amount of independent of the transcription factor remains unclear and is the RNA mixed in the DNA fragments acquired by MTA2 antibody focus of the present study. ChIP. After treatment with a variety of ribonucleases (RNases), The immunohistochemical staining image of MTA2 provided by the RNA content was sensitive to RNaseH, which could degrade the Human Protein Atlas revealed that MTA2 was highly expressed the RNA strand in RNA-DNA hybrids. RNA that occurs in the 1234567890();,: in hepatocellular carcinoma (HCC) cells and localized in the nuclei.
    [Show full text]
  • 8791.Full.Pdf
    Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis Da-Qiang Lia, Suresh B. Pakalaa, Sirigiri Divijendra Natha Reddya, Kazufumi Ohshiroa, Jun-Xiang Zhanga, Lei Wangb, Yanping Zhangc, Ignacio Moreno de Alboránd, M. Radhakrishna Pillaie, Jeyanthy Eswarana,f, and Rakesh Kumara,e,f,1 aDepartment of Biochemistry and Molecular Biology and fMcCormick Genomic and Proteomic Center, The George Washington University Medical Center, Washington, DC 20037; bDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; cRadiation Oncology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514; dDepartment of Immunology and Oncology, National Center for Biotechnology, 28049 Madrid, Spain; and eRajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, India Edited* by George R. Stark, Lerner Research Institute NE2, Cleveland, OH, and approved April 8, 2011 (received for review December 8, 2010) Although metastasis-associated protein 1 (MTA1), a componentofthe been reported to associate with proteins other than Mdm2 and to nucleosome remodeling and histone deacetylation complex, is widely have p53-independent tumor-suppressive activities (11). For ex- up-regulated in human cancers and correlates with tumor metastasis, ample, mice null for ARF, p53, and Mdm2 experienced tumor de- its regulatory mechanism and related signaling pathways remain velopment at a higher frequency than did mice lacking both p53 and unknown. Here, we report a previously unrecognized bidirectional Mdm2 or p53 alone (12). These studies indicate that the tumor- autoregulatory loop between MTA1 and tumor suppressor alter- suppressive functions of ARF are not elicited entirely through the native reading frame (ARF).
    [Show full text]
  • BTB Domain Dimerization: Development of a Protein-Protein Interaction Assay
    BTB domain dimerization: Development of a protein-protein interaction assay By Qingniao (Carol) Wang A thesis submitted in conformity with the requirement for the degree of Master of Science Graduate Department of Biochemistry University of Toronto © Copyright by Qingniao (Carol) Wang (2009) BTB domain dimerization: Development of a protein-protein interaction assay Qingniao (Carol) Wang Masters of Science 2009 Department of Biochemistry University of Toronto Abstract In the human genome, 43 BTB (Bric-à-brac, Tramtrack, and Broad Complex) containing BTB-Zinc Finger proteins have been identified, many of which are transcription factors involved in cancer and development. These BTB domains have been shown to form homodimers and heterodimers which raise DNA binding affinity and specificity for transcription factors. This project was to develop an efficient assay to systematically identify interactions between BTB domains. It combined a co-expression system, fluorescent protein tagging and Ni-NTA plate retention. It was concluded that fourteen analyzed BTB domains formed homodimers, but only certain BTB pairs formed heterodimers, such as BCL6 with Miz1 and Miz1 with RP58. To further understand the specificity of BTB domain interactions, more structural and sequence information is still needed. In conclusion, this assay provided a comprehensive detection method for BTB domain interaction mapping. The information generated provides candidates for further functional and structural studies. ii Acknowledgements This research project would not have been possible without the support of many people. I wish to express my gratitude to my supervisor, Dr. Gil Privé who offered invaluable guidance, assistance and patience. Special thanks are also due to the members of my supervisory committee, Dr.
    [Show full text]
  • Preleukemic Mutations in Human Acute Myeloid Leukemia Affect Epigenetic Regulators and Persist in Remission
    Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission M. Ryan Corces-Zimmermana, Wan-Jen Honga,b, Irving L. Weissmana,1, Bruno C. Medeirosb, and Ravindra Majetia,b,1 aProgram in Cancer Biology, Ludwig Center, Cancer Institute, Institute for Stem Cell Biology and Regenerative Medicine, and bDepartment of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305 Contributed by Irving L. Weissman, January 9, 2014 (sent for review December 23, 2013) Cancer is widely characterized by the sequential acquisition of (BCR-ABL) translocation occurs in HSCs, causing chronic disease, genetic lesions in a single lineage of cells. Our previous studies have but subsequent progression to blast crisis involves mutation evolu- shown that, in acute myeloid leukemia (AML), mutation acquisition tion at the level of granulocyte–macrophage progenitors (19, 20). occurs in functionally normal hematopoietic stem cells (HSCs). These More recently, a study of elderly women with clonal hematopoiesis preleukemic HSCs harbor some, but not all, of the mutations found indicated by X-inactivation skewing showed that these individuals in the leukemic cells. We report here the identification of patterns of harbored somatic ten eleven translocation methylcytosine dioxyge- TET2 mutation acquisition in human AML. Our findings support a model in nase 2 ( ) mutations, occurring at the level of the HSC, that which mutations in “landscaping” genes, involved in global chroma- may predispose them to hematologic malignancies (21). Recent work from our laboratory has provided direct evidence tin changes such as DNA methylation, histone modification, and supporting this model by demonstrating that, in a small subset of chromatin looping, occur early in the evolution of AML, whereas “ ” AML patients harboring mutations in the FMS-related tyrosine mutations in proliferative genes occur late.
    [Show full text]
  • LINE-1 Silencing by Retinoblastoma Proteins Is Effected Through the Nucleosomal and Remodeling Deacetylase Multiprotein Complex Diego E
    Montoya-Durango et al. BMC Cancer (2016) 16:38 DOI 10.1186/s12885-016-2068-9 RESEARCHARTICLE Open Access LINE-1 silencing by retinoblastoma proteins is effected through the nucleosomal and remodeling deacetylase multiprotein complex Diego E. Montoya-Durango1, Kenneth A. Ramos1, Pasano Bojang2, Lorell Ruiz1, Irma N. Ramos3 and Kenneth S. Ramos2* Abstract Background: Long Interspersed Nuclear Element-1 (L1) is an oncogenic mammalian retroelement silenced early in development via tightly controlled epigenetic mechanisms. We have previously shown that the regulatory region of human and murine L1s interact with retinoblastoma (RB) proteins to effect retroelement silencing. The present studies were conducted to identify the corepressor complex responsible for RB-mediated silencing of L1. Methods: Chromatin immunoprecipitation and silencing RNA technology were used to identify the repressor complex that silences L1 in human and murine cells. Results: Components of the Nucleosomal and Remodeling Deacetylase (NuRD) multiprotein complex specifically enriched the L1 5′-untranslated DNA sequence in human and murine cells. Genetic ablation of RB proteins in murine cells destabilized interactions within the NuRD macromolecular complex and mediated nuclear rearrangement of Mi2-β, an ATP-dependent helicase subunit with nucleosome remodeling activity. Depletion of Mi2-β, RbAP46 and HDAC2 reduced the repressor activity of the NuRD complex and reactivated a synthetic L1 reporter in human cells. Epigenetic reactivation of L1 in RB-null cells by DNA damage was markedly enhanced compared to wild type cells. Conclusions: RB proteins stabilize interactions of the NuRD corepressor complex within the L1 promoter to effect L1 silencing. L1 retroelements may serve as a scaffold on which RB builds heterochromatic regions that regulate chromatin function.
    [Show full text]